These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15013868)

  • 1. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion.
    Kuhli C; Scharrer I; Koch F; Ohrloff C; Hattenbach LO
    Am J Ophthalmol; 2004 Mar; 137(3):459-64. PubMed ID: 15013868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation disorders and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Scharrer I; Lüchtenberg M; Hattenbach LO
    Thromb Haemost; 2010 Feb; 103(2):299-305. PubMed ID: 20126828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of resistance to APC in young patients with retinal vein occlusion.
    Kuhli C; Hattenbach LO; Scharrer I; Koch F; Ohrloff C
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):163-8. PubMed ID: 11935272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective thrombophilia screening of young patients with retinal vein occlusion].
    Kuhli-Hattenbach C; Scharrer I; Lüchtenberg M; Hattenbach LO
    Klin Monbl Augenheilkd; 2009 Sep; 226(9):768-73. PubMed ID: 19399710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
    Pinna A; Carru C; Solinas G; Zinellu A; Carta F
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2747-52. PubMed ID: 17525208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
    Rehak M; Rehak J; Müller M; Faude S; Faude F; Siegemund A; Krcova V; Slavik L; Hasenclever D; Scholz M; Wiedemann P
    Thromb Haemost; 2008 May; 99(5):925-9. PubMed ID: 18449423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic abnormalities associated with various types of retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Podhajsky P
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):180-96. PubMed ID: 11935275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.
    Weger M; Renner W; Steinbrugger I; Cichocki L; Temmel W; Stanger O; El-Shabrawi Y; Lechner H; Schmut O; Haas A
    Ophthalmology; 2005 Nov; 112(11):1910-5. PubMed ID: 16157382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.
    Arsène S; Delahousse B; Regina S; Le Lez ML; Pisella PJ; Gruel Y
    Thromb Haemost; 2005 Jul; 94(1):101-6. PubMed ID: 16113792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome in patients with retinal venous occlusion.
    Paccalin M; Manic H; Bouche G; Landron C; Mercié M; Boinot C; Gombert JM; Roblot P; Dighiero P
    Thromb Res; 2006; 117(4):365-9. PubMed ID: 16461072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study.
    Sartori MT; Barbar S; Donà A; Piermarocchi S; Pilotto E; Saggiorato G; Prandoni P
    Eur J Haematol; 2013 May; 90(5):426-33. PubMed ID: 23461717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated lipoprotein (a) levels are an independent risk factor for retinal vein occlusion.
    Kuhli-Hattenbach C; Miesbach W; Lüchtenberg M; Kohnen T; Hattenbach LO
    Acta Ophthalmol; 2017 Mar; 95(2):140-145. PubMed ID: 27545749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts.
    Cugati S; Wang JJ; Knudtson MD; Rochtchina E; Klein R; Klein BE; Wong TY; Mitchell P
    Ophthalmology; 2007 Mar; 114(3):520-4. PubMed ID: 17141315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombophilia - a risk factor of retinal vein occlusion?].
    Karska-Basta I; Kubicka-Trzaska A; Romanowska-Dixon B; Undas A
    Klin Oczna; 2013; 115(1):29-33. PubMed ID: 23882736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of optic disk cupping to retinal vein occlusion: the Beaver Dam Eye Study.
    Klein BE; Meuer SM; Knudtson MD; Klein R
    Am J Ophthalmol; 2006 May; 141(5):859-62. PubMed ID: 16527230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal vein occlusion and the risk of acute myocardial infarction (correction of infraction): a 3-year follow-up study.
    Hu CC; Ho JD; Lin HC
    Br J Ophthalmol; 2009 Jun; 93(6):717-20. PubMed ID: 19208680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cox-2 inhibitors in patients with retinal venous occlusive disease.
    Recchia FM; Chen E; Li C; Maguluri S
    Retina; 2008 Jan; 28(1):134-7. PubMed ID: 18185149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinal vein occlusion and lipoprotein (a)].
    Ribeaudeau-Saindelle F; Glacet-Bernard A; Lelong F; Coscas G; Soubrane G
    J Fr Ophtalmol; 1998 Apr; 21(4):245-50. PubMed ID: 9759412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.